Authors: Donadio, M Manzin, E Berruti, A Bottini, A Gorzegno, G Danese, S DeFabiani, E Sarobba, MG Lorusso, V Castiglione, F Moro, G Bertetto, O Bumma, C Dogliotti, L

Citation: M. Donadio et al., Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretrested metastatic breast cancer patients. A multicenter phase II trial, CANC CHEMOT, 47(5), 2001, pp. 391-396

Authors: Fiorentino, C Berruti, A Bottini, A Bodini, M Brizzi, MP Brunelli, A Marini, U Allevi, G Aguggini, S Tira, A Alquati, P Olivetti, L Dogliotti, L

Citation: C. Fiorentino et al., Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients withoperable disease, BREAST CANC, 69(2), 2001, pp. 143-151

Authors: Bottini, A Berruti, A Bersiga, A Brizzi, MP Bruzzi, P Aguggini, S Brunelli, A Bolsi, A Bolsi, G Allevi, G Generali, D Betri, E Bertoli, G Alquati, P Dogliotti, L

Citation: A. Bottini et al., Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer, BR J CANC, 85(8), 2001, pp. 1106-1112

Authors: Bottini, A Berruti, A Bersiga, A Brizzi, MP Brunelli, A Gorzegno, G DiMarco, B Aguggini, S Bolsi, G Cirillo, F Filippini, L Betri, E Bertoli, G Alquati, P Dogliotti, L

Citation: A. Bottini et al., p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients, CLIN CANC R, 6(7), 2000, pp. 2751-2758

Authors: Berruti, A Sperone, P Bottini, A Gorzegno, G Lorusso, V Brunelli, A Botta, M Tampellini, M Donadio, M Mancarella, S De Lena, M Alquati, P Dogliotti, L

Citation: A. Berruti et al., Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines, J CL ONCOL, 18(19), 2000, pp. 3370-3377